Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonal Deletion and DAWN Protocol in Kidney Transplantation
NCT01408797Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Mar 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in kidney transplantation, sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Status: unknown.
02
Drugs
bortezomib
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01408797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408797.